SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-006476
Filing Date
2022-04-29
Accepted
2022-04-29 16:02:04
Documents
3
Period of Report
2022-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220622xdef14a.htm DEF 14A 644197
2 GRAPHIC tmb-20220622xdef14a004.jpg GRAPHIC 192217
3 GRAPHIC tmb-20220622xdef14a003.jpg GRAPHIC 173977
  Complete submission text file 0001558370-22-006476.txt   1149927
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39619 | Film No.: 22875064
SIC: 2836 Biological Products, (No Diagnostic Substances)